November 21st, 2019Follow on Twitter
November 20th, 2019Follow on Twitter
October 30th, 2019
WASHINGTON, D.C.— Today, Energy and Commerce Health Subcommittee Chairwoman Anna G. Eshoo (D-CA) held a hearing to address the inadequacies of the global pharmaceutical supply chain and the broken generic drug industry.
To watch Chairwoman Eshoo’s opening statement, click HERE.
“There is a hidden health care crisis in our country that will affect us all, and we’re not talking about it: the crippling inadequacy of the American drug supply.” Rep. Eshoo said. “I’m issuing a call to action to the FDA, to the pharmaceutical industry, and to my fellow Members of Congress to take this problem seriously and work with me to address it.”
Today, 90 percent of the medications that Americans take are generics because of affordability. But the generic industry faces serious threats affecting American public health and national security. The hearing addressed three major crises in the global pharmaceutical supply chain:
The hearing’s expert witnesses included Dr. Janet Woodcock from the Food and Drug Administration, Commissioner Michael Wessel of the U.S.-China Economic and Security Review Commission, Mr. David Gaugh from the Association for Accessible Medicines, and investigatory public health author Ms. Rosemary Gibson.
Congresswoman Eshoo is leading the effort to address threats posed by the global pharmaceutical supply chain, collaborating with Intelligence Committee Chairman Adam Schiff to address the public health and national security risks.
In this section, you will find information on the many ways my office can help you and your family. Below is a list of the issues we commonly address. If you cannot find what you're looking for, please either email me or call my Palo Alto District Office and we will do our best to answer any questions you may have.